These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4009403)

  • 21. Potentiation by bovine serum albumin (BSA) of endothelium-dependent vasodilator response to acetyl glyceryl ether phosphorylcholine (AGEPC).
    Shigenobu K; Tanaka Y; Maeda T; Kasuya Y
    J Pharmacobiodyn; 1987 May; 10(5):220-8. PubMed ID: 3625454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of platelet-activating factor on rat airways.
    Misawa M; Takata T
    Jpn J Pharmacol; 1988 Sep; 48(1):7-13. PubMed ID: 3199608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constriction of canine coronary arteries by platelet activating factor after brief ischemia.
    Kim YD; Danchak RM; Heim KF; Lees DE; Myers AK
    Prostaglandins; 1993 Sep; 46(3):269-76. PubMed ID: 8234834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasorelaxant effect of C16-PAF and C18-PAF on renal blood flow and systemic blood pressure in the anesthetized rat.
    Handa RK; Strandhoy JW; Buckalew VM
    Life Sci; 1991; 49(10):747-52. PubMed ID: 1875784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Putative mechanism of hypotensive action of platelet-activating factor in dogs.
    Yamanaka S; Miura K; Yukimura T; Okumura M; Yamamoto K
    Circ Res; 1992 May; 70(5):893-901. PubMed ID: 1568300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproducible vasodilatation by platelet-activating factor in blood- and Krebs-perfused rat kidneys is albumin-dependent.
    Gerkens JF
    Eur J Pharmacol; 1990 Feb; 177(3):119-26. PubMed ID: 2311673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar coronary vascular effects in the rat perfused heart of platelet-activating factor structural analogues with agonist and antagonist properties.
    Man RY; Kinnaird AA
    Br J Pharmacol; 1995 Nov; 116(5):2359-64. PubMed ID: 8581269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres.
    Wichrowski B; Jouquey S; Broquet C; Heymans F; Godfroid JJ; Fichelle J; Worcel M
    J Med Chem; 1988 Feb; 31(2):410-5. PubMed ID: 3339611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CV-3988 - a specific antagonist of platelet activating factor (PAF).
    Terashita Z; Tsushima S; Yoshioka Y; Nomura H; Inada Y; Nishikawa K
    Life Sci; 1983 Apr; 32(17):1975-82. PubMed ID: 6403793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries.
    Arner M; Högestätt ED
    Acta Physiol Scand; 1991 Jun; 142(2):165-72. PubMed ID: 1715111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indigo carmine inhibits endothelium-dependent and -independent vasodilation.
    Chang KS; Zhong MZ; Davis RF
    Hypertension; 1996 Feb; 27(2):228-34. PubMed ID: 8567045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.
    Handa RK; Strandhoy JW; Buckalew VM
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F108-16. PubMed ID: 1907104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor is a renal vasodilator in the anesthetized rat.
    Handa RK; Strandhoy JW; Buckalew VM
    Am J Physiol; 1990 Jun; 258(6 Pt 2):F1504-9. PubMed ID: 2360650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW; Wu MS; Biftu T
    J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depressed endothelium-dependent relaxation in hypertension: relation to increased blood pressure and reversibility.
    Van de Voorde J; Vanheel B; Leusen I
    Pflugers Arch; 1988 May; 411(5):500-4. PubMed ID: 3387186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of chronic ethanol treatment on endothelium-dependent responses in rat thoracic aorta.
    Williams SP; Adams RD; Mustafa SJ
    Alcohol; 1990; 7(2):121-7. PubMed ID: 2328085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney.
    Schwertschlag U; Scherf H; Gerber JG; Mathias M; Nies AS
    Circ Res; 1987 Apr; 60(4):534-9. PubMed ID: 3297384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin-induced lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor.
    McCormack DG; Crawley DE; Barnes PJ; Evans TW
    Clin Sci (Lond); 1992 Mar; 82(3):259-64. PubMed ID: 1372199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardionatrin causes vasodilation in vitro which is not dependent on the presence of endothelial cells.
    Scivoletto R; Carvalho MH
    Eur J Pharmacol; 1984 May; 101(1-2):143-5. PubMed ID: 6235120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.